MAPK3 and hepatocellular carcinoma: The study suggests that the Schisandra chinensis lignans and acteoside may counteract CCL20-induced epithelial-mesenchymal transition (EMT), invasion, and migration of hepatocellular carcinoma cells via the ERK1/2 pathway, while also promoting apoptosi (78).